Market research
CAMLINFINE.NSE Camlin Fine Sciences Limited
NSE INR Basic Materials
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 21B
- P/E ratio
- Not available
- Analyst target
- 152.5
- Dividend yield
- Not available
- Beta
- 0.68
Profile
Company facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- ISIN
- INE052I01032
- Market cap
- 21B
- P/E ratio
- Not available
- Analyst target
- 152.5
- Dividend yield
- Not available
- Beta
- 0.68
About
About Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its products under the Xtendra, Nasure, Ezential, adorr, Vitafor, Dinamic, and Biosus brands. The company's products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the CAMLINFINE.NSE discussion.
5 years, 5 months ago
Camlin Fine Sciences Limited is currently in a long term uptrend where the price is trading 51.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 1.6.
Camlin Fine Sciences Limited's total revenue rose by 8.8% to $3B since the same quarter in the previous year.
Its net income has increased by 199.0% to $154M since the same quarter in the previous year.
Finally, its free cash flow grew by 71.3% to $732M since the same quarter in the previous year.
Based on the above factors, Camlin Fine Sciences Limited gets an overall score of 5/5.